CDT EQUITY INC. Interest Expense on Debt
CDT EQUITY INC. (CDT) reported Interest Expense on Debt of $40.00 thousand for the 12-month period ending 2024-12-31, per its S-1 filed 2026-09-08.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseDebt · last filed 2026-09-08
- CDT EQUITY INC. interest expense, debt for the quarter ending 2024-12-31 was -$89.00K.
- CDT EQUITY INC. interest expense, debt for the quarter ending 2024-09-30 was $49.00K, a 16.67% increase year-over-year.
- CDT EQUITY INC. interest expense, debt for the quarter ending 2024-06-30 was $40.00K, a 2.56% increase year-over-year.
- CDT EQUITY INC. interest expense, debt for the quarter ending 2023-12-31 was -$86.00K.
- CDT EQUITY INC. interest expense, debt for fiscal 2023 was $0.00.
| Period end | Interest Expense, Debt 3 month | Interest Expense, Debt 6 month | Interest Expense, Debt 9 month | Interest Expense, Debt 12 month |
|---|---|---|---|---|
| 2024-12-31 | -$89.00K derived: S-1 12 month − 10-Q 9 month · filed 2026-09-08 | -$40.00K derived: sum of 2 quarters · filed 2026-09-08 | $0.00 derived: sum of 3 quarters · filed 2026-09-08 | $40.00K S-1 · filed 2026-09-08 |
| 2024-09-30 | $49.00K 10-Q · filed 2025-11-13 | $89.00K derived: sum of 2 quarters · filed 2025-11-13 | $129.00K 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $40.00K 10-Q/A · filed 2024-11-14 | $80.00K 10-Q/A · filed 2024-11-14 | ||
| 2023-12-31 | -$86.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | -$44.00K derived: sum of 2 quarters · filed 2025-03-28 | -$5.00K derived: sum of 3 quarters · filed 2025-03-28 | $0.00 10-K · filed 2025-03-28 |
| 2023-09-30 | $42.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2024-11-14 | $81.00K derived: sum of 2 quarters · filed 2024-11-14 | $86.00K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $39.00K 10-Q/A · filed 2024-11-14 | $44.00K 10-Q/A · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |